1. Partridge M.R., van der Molen T., Myrseth S. E., Busse W.W. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm. Med. 2006; 6: 13.
2. Чучалин А.Г., Цой А.Н., Архипов В.В., Гавришина Е.А. Бронхиальная астма в России: результаты национального исследования качества медицинской помощи больным бронхиальной астмой. Пульмонология 2006; 2: 94-102.
3. Holt S., Suder A., Weatherall M. et al. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. Brit. Med. J. 2001; 323: 1-8.
4. Masoli M., Holt S., Weatherall M., Beasley R. Doseresponse relationship of inhaled budesonide in adult asthma: a meta-analysis. Eur. Respir. J. 2004; 23: 552-558.
5. Bateman E.D., Boushey H.A., Bousquet J. et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL Study. Am. J. Respir. Crit. Care Med. 2004; 170: 836-844.
6. Tattersfield A.E., Postma D.S., Barnes P.J. et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. Am. J. Respir. Crit. Care Med. 1999; 160: 594-599.
7. GINA Report, Global Strategy for Asthma Management and Prevention. Published November 2006. http://www.ginasthma.org/download.asp?intId=217
8. Pauwels R., Lofdahl C.G., Postma D.S. et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 1997; 337 (20): 1405.
9. FitzGerald J.M., Becker A., Sears M.R. et al. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 2004; 59: 550-556.
10. Harrison T.W., Oborne J., Newton S. et al. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 2004; 363: 271-275.
11. Reddel H.K., Barnes D.J. Pharmacological strategies for self-management of asthma exacerbations. Eur. Respir. J. 2006; 28 (1): 182-199.
12. Fitzgerald M. et al. Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: A five-month multicentre Canadian study. Can. Respir. J. 2003; 10: 427-434.
13. Stallberg B., Olsson P., Jorgensen L.A., Lindarck N., Ekstrom T. Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing. Int. J. Clin. Pract. 2003; 57 (8): 656-661.
14. Buhl R., Kardos P., Richter K. et al. The effect of adjustable dosing with budesonide/formoterol on health?related quality of life and asthma control compared with fixed dosing. Cur. Med. Res. Opin. 2004; 20 (8): 1209?1220.
15. Serrier P., Roche N., Pello J.Y., Larguier J.S., Mezzi K. Control of asthma by treatment with inhaled corticosteroids and prolonged action beta 2-agonists in free or fixed combination. Results of the ALISE study. Fr. Pres. Med. 2003; 32 (11): 493-497.
16. Aalbers R., Backer V., Kava T.T.K. et al. Adjustable maintenance dosing with budesonide/formoterol compared with fixed dose salmeterol/fluticasone in moderate to severe asthma. Cur. Med. Res. Opin. 2004; 20 (2): 225-240.
17. Gibson P.G. Teaching old drugs new tricks: asthma therapy adjusted by patient perception or noninvasive markers. Eur. Respir. J. 2005; 25: 397-399.
18. Ringdal N. et al. Respir. Med. 1998; 92: 1017-1021.
19. Busse W.W. et al. J. Allergy Clin. Immunol. 1998; 101: 457-463.
20. Vathenen A.S., Knox A.J., Wisniewski A., Tattersfield A.E. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am. Rev. Respir. Dis. 1991; 143: 1317-1321.
21. Le Merre C., Bengtsson T., Carlholm M., Ostinelli J. Effect on lung function and inflammatory markers of single doses of inhaled budesonide in asthmatics. Am. J. Respir. Crit. Care Med. 1997; 155: A352.
22. Fitzgerald J.M., Shragge D., Haddon J. et al. A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation. Can. Respir. J. 2000; 7: 61-67.
23. Nana A., Youngchaiyud P., Charoenratanakul S. et al. Highdose inhaled budesonide may substitute for oral therapy after an acute asthma attack. J. Asthma 1998; 35: 647-655.
24. Pauwels R.A., Sears M.R., Campbell M. et al. Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur. Respir. J. 2003; 22: 787-794.
25. Ind P.W., Villasante C., Shiner R.J. et al. Safety of formoterol by Turbuhaler1 as reliever medication compared with terbutaline in moderate asthma. Eur. Respir. J. 2002; 20: 859-866.
26. Jonkers R.E., Bantje T.A., Aalbers R. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. Respir. Res. 2006; 7: 141.
27. Balanag V.M., Yunus F., Yang P.C., Jorup C. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Pulm. Pharmacol. Ther. 2006; 19 (2): 139-147.
28. van der Woude H.J., Boorsma M., Bergqvist P.B. et al. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. Pulm. Pharmacol. Ther. 2004; 17 (2): 89-95.
29. Rabe K.F., Pizzichini E., Bjorn Stallberg B. et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma. Chest 2006; 129: 246-256.
30. Scicchitano R., Aalbers R., Ukena D. et al. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Cur. Med. Res. Opin. 2004;20 (9): 1403-1418.
31. O'Byrne P.M., Bisgaard H., Godard P.P. et al. Budesonide/ formoterol combination therapy as both maintenance and reliever medication in asthma. Am. J. Respir. Crit. Care Med. 2005; 171: 129-136.
32. Rabe K.F., Atienza T., Magyar P. et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006; 368 (9537): 744-753.
33. Vogelmeier C., D'Urzo A., Pauwels R. et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur. Respir. J. 2005; 26 (5): 819-828.
34. Kuna P., Peters M.J., Buhl R. Budesonide/formoterol as maintenance and reliever therapy reduces asthma exacerbations versus a higher maintenance dose of budesonide/formoterol or salmeterol/fluticasone. Abstract presented at the ERS Congress 2006.